Skip to main content
. 2019 Jan 28;41(7):2116–2122. doi: 10.1002/hed.25667

Table 2.

Univariate analysis of clinicopathological risk factors for cervical nodal metastasis

Variables pN status
pN− (No. = 25) pN+ (No. = 102) P value
Age (mean ± SD, years) 59.4 ± 9.3 56.6 ± 9.1 0.18a
Sex, n (%)
Male 25 (100.0) 99 (97.0)
Female 0 (0.0) 3 (3.0)
Tumor site, n (%) 0.1b
Hypopharynx 15 (37.0) 78 (76.0)
Supraglottis 10 (63.0) 24 (24.0)
pT classificationc, n (%) 0.53b
T1 6 (24.0) 14 (13.7)
T2 13 (52.0) 54 (53.0)
T3 2 (8.0) 16 (15.7)
T4 4 (16.0) 18 (17.6)
Histological grading, n (%) 0.26b
G1 2 (7.4) 3 (3.0)
G2 19 (77.8) 70 (68.0)
G3 4 (14.8) 29 (29.0)
Perineural invasion, n (%) 1.000b
22 (88.0) 88 (86.3)
+ 3 (12.0) 14 (13.7)
Lymphovascular invasion, n (%) 0.02 b
24 (92.6) 77 (76.0)
+ 1 (7.4) 25 (24.0)
Maximal tumor diameter (mean ± SD, mm) 28.4 ± 13.0 31.0 ± 14.2 0.4a
Tumor depth (mean ± SD, mm) 2.0 ± 1.3 7.4 ± 3.0 <0.0001 a

Abbreviations: CI, confidence interval; G1, well differentiated; G2, moderately differentiated; G3, poorly differentiated; OR, odds ratio; pN−, pathologically negative nodal metastasis; pN+, pathologically positive nodal metastasis; pT Classification, pathological tumor classification.

Bold values show P‐value<0.05.

a

Mann‐Whitney U test, P < 0.05.

b

Chi‐square test or Fisher's exact test, P < 0.05.

c

Tumor node metastasis staging system according to the American Joint Committee on Cancer (7th edition).